上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白,专注于信号通路和疾病研究领域。
ATR-IN-12
ATR-IN-12 (Compound 5g) 是一种有效的共济失调毛细血管扩张和 Rad3 相关 (ATR) 激酶抑制剂,IC50 值 0.007 μM。ATR-IN-12 显示出良好的抗肿瘤活性并显着降低 ATR 及其下游信号蛋白的磷酸化水平。ATR-IN-12 是一种很有前途的先导化合物,可用于后续针对 ATR 激酶的药物发现。
ATR-IN-12 Chemical Structure
规格 | 是否有货 | ||
---|---|---|---|
100 mg | 询价 | ||
250 mg | 询价 | ||
500 mg | 询价 |
* Please select Quantity before adding items.
生物活性 |
ATR-IN-12 (Compound 5g) is a potent inhibitor of ataxia telangiectasia and Rad3-related (ATR) kinase with an IC50 value of 0.007 μM. ATR-IN-12 displays good anti-tumor activity and significantly reduces the phosphorylation level of ATR and its downstream signaling protein. ATR-IN-12 is a promising lead compound for subsequent drug discovery targeting ATR kinase[1]. |
---|---|
分子量 |
441.55 |
Formula |
C22H27N5O3S |
运输条件 |
Room temperature in continental US; may vary elsewhere. |
储存方式 |
Please store the product under the recommended conditions in the Certificate of Analysis. |
参考文献 |
|
所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务